Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • BW TV
  • Subscribe to Print

Latest Articles in sanofi

Panacea Biotec Files Suit Against Sanofi For Patent Infringement

Panacea said Sanofi has been contesting the patent before the Indian Patent Office since 2017, where the dispute has spilled before the Bombay and Delhi High Courts in 2018 and 2019, respectively.

Read More

Sanofi India Q1 Net Profit At Rs 145.9 Cr

Revenue from operations of the company stood at Rs 725.1 crore for the quarter under consideration. It was Rs 784.5 crore for the same period a year ago

Read More

Sanofi, GSK start phase 2 trial of their COVID-19 vaccine, phase 3 could begin by April

Sanofi, GSK start phase 2 trial of their COVID-19 vaccine, phase 3 could begin by April

Read More

Sanofi Eyes More Cost Cuts To Boost Profitability

Total sales rose 4.2% to 9.4 billion euros thanks to another strong revenue increase of its eczema treatment Dupixent and what it described as a "record demand" for its influenza vaccines.

Read More

Sanofi Says Could Help Produce Competitors' COVID-19 Shots

Sanofi and Britain's GlaxoSmithKline said a COVID-19 vaccine they are jointly developing had showed an insufficient immune response in older people, delaying its launch to late next year, in a setback for both companies.

Read More

Drugmakers To Hike Prices For 2021 As Pandemic, Political Pressure Put Revenues At Risk

Teva Pharmaceuticals Inc hiked prices on 15 drugs, including Austedo, which treats rare neurological disorders, and asthma steroid Qvar, which together grossed more than $650 million in sales in 2019 and saw price hikes of between 5% and 6%.

Read More

Sanofi Renews Deal With WHO To Fight Tropical Diseases, Sleeping Sickness

Sanofi said its new five-year commitment with the WHO would see Sanofi provide financial support of $5 million per year over those five years, to finance research and work dedicated to tackling those ailments.

Read More

Sanofi And GSK Delay COVID-19 Vaccine, Marking Setback To Global Fight

Sanofi is also working on another vaccine candidate to prevent COVID-19 with U.S. company Translate Bio which will rely on a different technology called mRNA, similar to the developed by Pfizer and Moderna.

Read More

Russia's Sputnik V developers ready to share technology with Sanofi / GSK amid vaccine delay

Russia's Sputnik V developers ready to share technology with Sanofi / GSK amid vaccine delay

Read More

Sanofi To Publish COVID-19 Vaccine Price In Development With GSK After Phase I/II Trial Results

It is also developing a vaccine with U.S. biotech firm Translate Bio, with clinical human trials expected to start this month.

Read More

Healthcare Group Sanofi Offers To Buy Smaller Peer Kiadis For 308 Mln Euros

Shares in Kiadis, focused on cell-based immunotherapy products for the treatment of cancer, were up 245% in early trading. Sanofi shares were up 1.18%.

Read More

Sanofi Raises Outlook As Specialty Care And Vaccines Lift Sales

Revenue in Sanofi's vaccine arm was up 13.6% at constant exchange rates to 2 billion euros ($2.36 billion) in the third quarter, which it said was due to record flu sales.

Read More

GSK, Sanofi To Make 200 Million Doses Available For COVID-19 Vaccine Alliance

GSK-Sanofi has currently signed a $2.1 billion deal with the U.S. to supply it with more than 100 million doses of its coronavirus vaccine candidate. The companies also have deals with the European Union and UK.

Read More

Sanofi Pasteur Launches Dtap-IPV Booster Vaccine In India For Preschoolers

The four-in-one (DTaP-IPV) vaccine named 'Tetraxim' by reducing the number of injections, increases comfort and improves vaccination compliance for children and reduces parental anxiet

Read More

Sanofi, GSK Launch Trial For COVID-19 Protein-based Vaccine

If the results are conclusive, Sanofi and GSK hope to get the vaccine approved in the first half of next year.

Read More